All In Biotech

Drug Trial Radar · NCT06359899

A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Investigate the Efficacy, Safety and Tolerability of Oral Administered AK0901 Capsules in Children Aged 6-12 Years Old With Attention Deficit Hyperactivity Disorder

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

55

Actual

Start

May 28, 2024

Primary completion

Jan 6, 2025

Study completion Jan 11, 2025

Sponsor

Sponsor type
Industry
First posted
Apr 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase 3, multicenter, dose-optimized, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy, safety, and tolerability of oral AK0901 capsules in children 6 to 12 years old with Attention Deficit Hyperactivity Disorder(ADHD).

Conditions

  • ADHD

Interventions

  • AK0901 capsuleDrug

    Active Substance: AK0901, Pharmaceutical Form: Capsule, Route of Administration: Oral

  • PlaceboDrug

    Active Substance: Placebo, Pharmaceutical Form: Capsule, Route of Administration: Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of AK0901 compared to placebo in children 6 to 12 years old with ADHD.Time frame: From Baseline (Pre-dose on Day 1) to week 3

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing anding hospital capital medical university

    Beijing, Beijing Municipality, China

  • Peking university sixth hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.